Drug
HU-045 clinical trials
Also written HU-045.
Keep track of what changes. Save the HU-045 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses HU-045 is read from its arms, and is right about nine times in ten.
Testing it · 3
- To Evaluate HU-045 With Moderate to Severe Glabellar LinesRecruitingPhase 3Huons BiopharmaNCT07870694Written as HU-045
- To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)RecruitingPhase 3Huons BiopharmaNCT06205797Written as HU-045
- Phase 2 of HU-045 in Glabellar LinesCompletedPhase 2Huons Co., Ltd.NCT05298449Written as HU-045